期刊文献+

维持性血液透析患者N-末端脑钠肽前体与心血管事件的临床研究 被引量:4

Clinical Research of Relationship between N-terminal Pro-Brain Natriuretic Peptide Levels and Cardiovascular Events in Maintenance Hemodialysis Patients
在线阅读 下载PDF
导出
摘要 目的:探讨N-末端脑钠肽前体(NT-proBNP)在评估维持性血液透析患者心血管事件发生中的意义。方法:选取我院维持性血液透析患者92例,应用电化学发光法检测NT-proBNP,同时应用彩色多普勒超声心动图测定患者的左室舒张末内径(LIDd)、左室后壁厚度(LVPWT)、舒张末室间隔厚度(IVST)、左室射血分数(LVEF),并记录患者的一般情况及临床各项指标并随访观察半年,记录随访期间血透患者发生的心血管事件。结果:所有血透患者的NT-proBNP水平均高于正常值,在半年随访期间共发生心血管事件17例(其中死亡4例)。事件组NT-proBNP中位数为24732ng/L,非事件组NT-proBNP中位数为2329ng/L,两组差异有统计学意义(P<0.01)。Logistic回归分析证实NT-proBNP是血透患者心血管事件发生的独立危险因子。结论:NT-proBNP作为一项有用的生物学标记物可以预测维持性血透患者心血管事件的发生。 Objective:To investigate the relationship between N - terminal pro- brain natriuretic peptide (NT- proBNP) levels and cardiovascular events in maintenance hemodialysis patients. Methods: A prospective cohort study was conducted in 92 maintenance hemodialysis patients. Serum NT-proBNP was measured using electrochemiluminescence immunoassay, together with echocardiography and dialysis indices. Each patient was followed up for six months. Results: Concentrations of NT- proBNP increased in all of the patients. During the follow up period, 17 patients underwent a cardiovascular event (4 patients died). The median NT- proBNP level in event group was significantly higher than in non - event group ( 24 732 ng/L vs. 2 329 ng/L, P 〈 0.01 ). NT - proBNP was revealed to be the strong independent predictor of cardiovascular events by multiple logistic regression analysis. Conclusion: Plasma NT- proBNP is a useful biochemical marker to predict the ocurrence of cardiovascular event in maintenance hemodialysis patients.
出处 《中国中西医结合肾病杂志》 2009年第6期509-512,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 上海市医苑新星基金资助项目(No.02xx46)
关键词 维持性血液透析 N-末端脑钠肽前体 心血管事件 Maintenance hemodialysis NT-proBNP Cardiovascular events
  • 相关文献

参考文献19

  • 1Vasan RS, Benjamin EJ, Larson MG, et al. Plasma natriuretic peptides for community ,screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA, 2002,288(10) : 1252 - 1259.
  • 2Yamamoto K, Bumett JC Jr, Berrnudez EA, et al. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail,2000,6(3) : 194 - 200.
  • 3Williams SG, Ng LL, O' Brien R J, et al. Is plasma N - BNP a good indicator of the functional reserve of failing hearts? The FRESHBNP study. Eur J Heart Fail,2004,6(7) :891 - 900.
  • 4Mueller C, Scholer A, Laule - Kilian K, et al. Use of B - type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med, 2004,350 (7) : 647 - 654.
  • 5Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med,2002,347(3) : 161- 167.
  • 6Pemberton CJ, Johnson ML, Yandle TG, et al. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension, 2000,36 (3): 355 - 359.
  • 7Tsuruda T, Kato J, Sumi T, et al. Combined use of brain natriuretic peptide and C- reactive protein for predicting cardiovascular risk in outpatients with type2 diabetes mellitus. Vasc Health Risk Manag, 2007,3 (4) :417 - 423.
  • 8Gillum RF, Fortmann SP, Prineas R J, et al. International diagnostic criteria for acute myocardial infarction and acute stroke.Am HeartJ,1984,108(1):150 - 158.
  • 9Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham Study. Am Heart J, 1988, 115 (4) : 869 - 875.
  • 10Becker A, Bos G, de Vegt F, et al. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10 - year follow- up of the Hoom Study. Eur Heart J ,2003,24(15) : 1406 - 1413.

同被引文献56

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部